{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T18:56:23Z","timestamp":1772045783848,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00210-024-03287-1","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T11:03:10Z","timestamp":1721041390000},"page":"533-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine"],"prefix":"10.1007","volume":"398","author":[{"given":"Sheyda Jodeiry","family":"Zaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoudreza","family":"Aghamaali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souzan","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Samad","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Doustvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazila","family":"Mozammel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Ali","family":"Mokhtarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"3287_CR1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/cgt.2009.88","volume":"17","author":"Y Akao","year":"2010","unstructured":"Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, Nakashima R, Kitade Y, Naoe T (2010) Role of anti-oncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Ther 17:398\u2013408","journal-title":"Cancer Gene Ther"},{"key":"3287_CR2","first-page":"933","volume":"12","author":"M Alam","year":"2022","unstructured":"Alam M, Alam S, Shamsi A, Adnan M, Elasbali AM, Al-Soud WA, Alreshidi M, Hawsawi YM, Tippana A, Pasupuleti VR (2022) Bax\/Bcl-2 cascade is regulated by the EGFR pathway: Therapeutic targeting of non-small cell lung cancer. Front Oncol 12:933","journal-title":"Front Oncol"},{"key":"3287_CR3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/B978-0-444-52138-5.00022-0","volume":"104","author":"F Attenello","year":"2012","unstructured":"Attenello F, Raza SM, Dimeco F, Olivi A (2012) Chemotherapy for brain tumors with polymer drug delivery. Handb Clin Neurol 104:339\u2013353","journal-title":"Handb Clin Neurol"},{"key":"3287_CR4","doi-asserted-by":"crossref","first-page":"118688","DOI":"10.1016\/j.bbamcr.2020.118688","volume":"1867","author":"A Boice","year":"2020","unstructured":"Boice A, Bouchier-Hayes L (2020) Targeting apoptotic caspases in cancer. Biochim Biophys Acta Mol Cell Res 1867:118688","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3287_CR5","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1111\/j.1742-4658.2009.07383.x","volume":"276","author":"PM Borralho","year":"2009","unstructured":"Borralho PM, Kren BT, Castro RE, Moreira da Silva IB, Steer CJ, Rodrigues CM (2009) MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J 276:6689\u20136700","journal-title":"FEBS J"},{"key":"3287_CR6","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/ijms21061950","volume":"21","author":"A Buruian\u0103","year":"2020","unstructured":"Buruian\u0103 A, Florian \u0218I, Florian AI, Timi\u0219 T-L, Mihu CM, Micl\u0103u\u0219 M, O\u0219an S, Hrap\u0219a I, Cataniciu RC, Farca\u0219 M (2020) The roles of miRNA in glioblastoma tumor cell communication: Diplomatic and aggressive negotiations. Int J Mol Sci 21:1950","journal-title":"Int J Mol Sci"},{"key":"3287_CR7","doi-asserted-by":"crossref","first-page":"17202","DOI":"10.18632\/aging.203171","volume":"13","author":"H Cao","year":"2021","unstructured":"Cao H, Wang D, Gao R, Chen L, Feng Y, Gao D (2021) Zhoushi Qiling decoction induces apoptosis of human prostate cancer cells via miR-143\/Bcl-2 axis. Aging (Albany NY) 13:17202","journal-title":"Aging (Albany NY)"},{"key":"3287_CR8","doi-asserted-by":"crossref","first-page":"84384","DOI":"10.18632\/oncotarget.21037","volume":"8","author":"L Chang","year":"2017","unstructured":"Chang L, Zhang D, Shi H, Bian Y, Guo R (2017) MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1. Oncotarget 8:84384\u201384395","journal-title":"Oncotarget"},{"key":"3287_CR9","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.3390\/ijms19102879","volume":"19","author":"M Da Ros","year":"2018","unstructured":"Da Ros M, De Gregorio V, Iorio AL, Giunti L, Guidi M, De Martino M, Genitori L, Sardi I (2018) Glioblastoma chemoresistance: the double play by microenvironment and blood-brain barrier. Int J Mol Sci 19:2879","journal-title":"Int J Mol Sci"},{"key":"3287_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0156-6","volume":"15","author":"AV Das","year":"2015","unstructured":"Das AV, Pillai RM (2015) Implications of miR cluster 143\/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int 15:1\u201312","journal-title":"Cancer Cell Int"},{"key":"3287_CR11","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/ijms23052607","volume":"23","author":"Y Esemen","year":"2022","unstructured":"Esemen Y, Awan M, Parwez R, Baig A, Rahman S, Masala I, Franchini S, Giakoumettis D (2022) Molecular pathogenesis of glioblastoma in adults and future perspectives: a systematic review. Int J Mol Sci 23:2607","journal-title":"Int J Mol Sci"},{"key":"3287_CR12","first-page":"2585","volume":"6","author":"HS Friedman","year":"2000","unstructured":"Friedman HS, Kerby T, Calvert H (2000) Temozolomide and treatment of malignant glioma. Clin Cancer Res 6:2585\u20132597","journal-title":"Clin Cancer Res"},{"key":"3287_CR13","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1158\/1078-0432.CCR-05-0060","volume":"11","author":"TF Gajewski","year":"2005","unstructured":"Gajewski TF, Sosman J, Gerson SL, Liu L, Dolan E, Lin S, Vokes EE (2005) Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1, 3-bis (2-chloroethyl)-1-nitrosourea in advanced melanoma. Clin Cancer Res 11:7861\u20137865","journal-title":"Clin Cancer Res"},{"key":"3287_CR14","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/jcp.26810","volume":"234","author":"M Ghasabi","year":"2019","unstructured":"Ghasabi M, Mansoori B, Mohammadi A, Duijf PH, Shomali N, Shirafkan N, Mokhtarzadeh A, Baradaran B (2019) MicroRNAs in cancer drug resistance: Basic evidence and clinical applications. J Cell Physiol 234:2152\u20132168","journal-title":"J Cell Physiol"},{"key":"3287_CR15","doi-asserted-by":"crossref","first-page":"e0191607","DOI":"10.1371\/journal.pone.0191607","volume":"13","author":"SE Gomes","year":"2018","unstructured":"Gomes SE, Pereira DM, Roma-Rodrigues C, Fernandes AR, Borralho PM, Rodrigues CM (2018) Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells. PLoS ONE 13:e0191607","journal-title":"PLoS ONE"},{"key":"3287_CR16","first-page":"3","volume":"18","author":"F Hanif","year":"2017","unstructured":"Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU (2017) Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev 18:3","journal-title":"Asian Pac J Cancer Prev"},{"key":"3287_CR17","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.2174\/1871520623666230718145100","volume":"23","author":"SS Hosseini","year":"2023","unstructured":"Hosseini SS, Nazifi P, Amini M, Zargari F, Yari AH, Baradaran B, Mahboob S, Mokhtarzadeh A (2023) Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143\/145 and KRAS\/RREB1 Pathways. Anticancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 23:1916\u20131923","journal-title":"Anticancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"3287_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28872-2","volume":"8","author":"A Hossian","year":"2018","unstructured":"Hossian A, Sajib M, Tullar PE, Mikelis CM, Mattheolabakis G (2018) Multipronged activity of combinatorial miR-143 and miR-506 inhibits lung cancer cell cycle progression and angiogenesis in vitro. Sci Rep 8:1\u201314","journal-title":"Sci Rep"},{"key":"3287_CR19","first-page":"1","volume":"9","author":"A Iio","year":"2010","unstructured":"Iio A, Nakagawa Y, Hirata I, Naoe T, Akao Y (2010) Identification of non-coding RNAs embracing microRNA-143\/145 cluster. Mol Cancer 9:1\u20137","journal-title":"Mol Cancer"},{"key":"3287_CR20","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","volume":"67","author":"MV Iorio","year":"2007","unstructured":"Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu C-G, Alder H (2007) MicroRNA signatures in human ovarian cancer. Can Res 67:8699\u20138707","journal-title":"Can Res"},{"key":"3287_CR21","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0960-9776(11)70297-1","volume":"20","author":"MV Iorio","year":"2011","unstructured":"Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E (2011) Breast cancer and microRNAs: therapeutic impact. Breast 20:S63\u2013S70","journal-title":"Breast"},{"key":"3287_CR22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jconrel.2022.07.027","volume":"349","author":"JM Jim\u00e9nez-Morales","year":"2022","unstructured":"Jim\u00e9nez-Morales JM, Hern\u00e1ndez-Cuenca YE, Reyes-Abrahantes A, Ruiz-Garc\u00eda H, Barajas-Olmos F, Garc\u00eda-Ortiz H, Orozco L, Qui\u00f1ones-Hinojosa A, Reyes-Gonz\u00e1lez J, del Carmen A-P\u00e9rez M (2022) MicroRNA delivery systems in glioma therapy and perspectives: A systematic review. J Control Release 349:712\u2013730","journal-title":"J Control Release"},{"key":"3287_CR23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2015.06.137","volume":"468","author":"S-S Kim","year":"2015","unstructured":"Kim S-S, Harford JB, Pirollo KF, Chang EH (2015) Effective treatment of glioblastoma requires crossing the blood\u2013brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem Biophys Res Commun 468:485\u2013489","journal-title":"Biochem Biophys Res Commun"},{"key":"3287_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2016.03.001","volume":"80","author":"W-h Li","year":"2016","unstructured":"Li W-h, Wu H-j, Li Y-x, Pan H-g, Meng T, Wang X (2016) MicroRNA-143 promotes apoptosis of osteosarcoma cells by caspase-3 activation via targeting Bcl-2. Biomed Pharmacother 80:8\u201315","journal-title":"Biomed Pharmacother"},{"key":"3287_CR25","doi-asserted-by":"crossref","unstructured":"Lin K-I, Lin C-C, Kuo S-M, Lai J-C, Wang Y-Q, You H-L, Hsu M-L, Chen C-H, Shiu L-Y\u00a0(2018) Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma. Biosci Rep 38:BSR20180005","DOI":"10.1042\/BSR20180005"},{"key":"3287_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2015.10.153","volume":"468","author":"J Liu","year":"2015","unstructured":"Liu J, Qu C-B, Xue Y-X, Li Z, Wang P, Liu Y-h (2015) MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells. Biochem Biophys Res Commun 468:105\u2013112","journal-title":"Biochem Biophys Res Commun"},{"key":"3287_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.canlet.2012.10.017","volume":"328","author":"S Noguchi","year":"2013","unstructured":"Noguchi S, Yasui Y, Iwasaki J, Kumazaki M, Yamada N, Naito S, Akao Y (2013) Replacement treatment with microRNA-143 and-145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K\/Akt and MAPK signaling pathways. Cancer Lett 328:353\u2013361","journal-title":"Cancer Lett"},{"key":"3287_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2009.06.034","volume":"386","author":"J Novakova","year":"2009","unstructured":"Novakova J, Slaby O, Vyzula R, Michalek J (2009) MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386:1\u20135","journal-title":"Biochem Biophys Res Commun"},{"key":"3287_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-010-0709-x","volume":"351","author":"MS Ola","year":"2011","unstructured":"Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351:41\u201358","journal-title":"Mol Cell Biochem"},{"key":"3287_CR30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fphys.2018.00170","volume":"9","author":"E Ozdemir-Kaynak","year":"2018","unstructured":"Ozdemir-Kaynak E, Qutub AA, Yesil-Celiktas O (2018) Advances in glioblastoma multiforme treatment: new models for nanoparticle therapy. Front Physiol 9:170","journal-title":"Front Physiol"},{"key":"3287_CR31","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.onc.1210809","volume":"27","author":"M Ozen","year":"2008","unstructured":"Ozen M, Creighton C, Ozdemir M, Ittmann M (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27:1788\u20131793","journal-title":"Oncogene"},{"key":"3287_CR32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/cancers12030708","volume":"12","author":"V Poli","year":"2020","unstructured":"Poli V, Secl\u00ec L, Avalle L (2020) The microRNA-143\/145 cluster in tumors: a matter of where and when. Cancers 12:708","journal-title":"Cancers"},{"key":"3287_CR33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10495-020-01601-9","volume":"25","author":"P Ramesh","year":"2020","unstructured":"Ramesh P, Medema JP (2020) BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy. Apoptosis 25:305\u2013320","journal-title":"Apoptosis"},{"key":"3287_CR34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.freeradbiomed.2019.12.043","volume":"152","author":"T Rezaei","year":"2020","unstructured":"Rezaei T, Amini M, Hashemi ZS, Mansoori B, Rezaei S, Karami H, Mosafer J, Mokhtarzadeh A, Baradaran B (2020) microRNA-181 serves as a dual-role regulator in the development of human cancers. Free Radical Biol Med 152:432\u2013454","journal-title":"Free Radical Biol Med"},{"key":"3287_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02349-7","volume":"41","author":"L Rong","year":"2022","unstructured":"Rong L, Li N, Zhang Z (2022) Emerging therapies for glioblastoma: Current state and future directions. J Exp Clin Cancer Res 41:1\u201318","journal-title":"J Exp Clin Cancer Res"},{"key":"3287_CR36","doi-asserted-by":"crossref","unstructured":"Sanada H, Seki N, Mizuno K, Misono S, Uchida A, Yamada Y, Moriya S, Kikkawa N, Machida K, Kumamoto T, Suetsugu T, Inoue H (2019) Involvement of dual strands of miR-143 (miR-143\u20135p and miR-143\u20133p) and their target oncogenes in the molecular pathogenesis of lung adenocarcinoma. Int J Mol Sci 20:4482","DOI":"10.3390\/ijms20184482"},{"key":"3287_CR37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fonc.2019.00963","volume":"9","author":"OG Taylor","year":"2019","unstructured":"Taylor OG, Brzozowski JS, Skelding KA (2019) Glioblastoma multiforme: an overview of emerging therapeutic targets. Front Oncol 9:963","journal-title":"Front Oncol"},{"key":"3287_CR38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/bjc.2013.313","volume":"109","author":"S Wach","year":"2013","unstructured":"Wach S, Nolte E, Theil A, St\u00f6hr C, Rau TT, Hartmann A, Ekici A, Keck B, Taubert H, Wullich B (2013) MicroRNA profiles classify papillary renal cell carcinoma subtypes. Br J Cancer 109:714\u2013722","journal-title":"Br J Cancer"},{"key":"3287_CR39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s10038-020-0795-x","volume":"65","author":"M Wada","year":"2020","unstructured":"Wada M, Goto Y, Tanaka T, Okada R, Moriya S, Idichi T, Noda M, Sasaki K, Kita Y, Kurahara H (2020) RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: Oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation. J Hum Genet 65:1019\u20131034","journal-title":"J Hum Genet"},{"key":"3287_CR40","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.18632\/oncotarget.2116","volume":"5","author":"L Wang","year":"2014","unstructured":"Wang L, Shi Z-m, Jiang C-f, Liu X, Chen Q-d, Qian X, Li D-m, Ge X, Wang X-f, Liu L-Z (2014) MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Oncotarget 5:5416","journal-title":"Oncotarget"},{"key":"3287_CR41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3892\/ol.2016.5388","volume":"13","author":"H Wang","year":"2017","unstructured":"Wang H, Li Q, Niu X, Wang G, Zheng S, Fu G, Wang Z (2017) miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signaling. Oncol Lett 13:435\u2013440","journal-title":"Oncol Lett"},{"key":"3287_CR42","doi-asserted-by":"crossref","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE (2021) Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res 171:105780","journal-title":"Pharmacol Res"},{"key":"3287_CR43","doi-asserted-by":"crossref","unstructured":"Xiao Z-Z, Wang Z-F, Lan T, Huang W-H, Zhao Y-H, Ma C, Li Z-Q (2020) Carmustine as a supplementary therapeutic option for glioblastoma: a systematic review and meta-analysis. Front Neurol\u00a011:1036","DOI":"10.3389\/fneur.2020.01036"},{"key":"3287_CR44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11010-010-0700-6","volume":"350","author":"B Xu","year":"2011","unstructured":"Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N (2011) miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem 350:207\u2013213","journal-title":"Mol Cell Biochem"},{"key":"3287_CR45","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00383-010-2700-8","volume":"26","author":"T Yamagata","year":"2010","unstructured":"Yamagata T, Yoshizawa J, Ohashi S, Yanaga K, Ohki T (2010) Expression patterns of microRNAs are altered in hypoxic human neuroblastoma cells. Pediatr Surg Int 26:1179\u20131184","journal-title":"Pediatr Surg Int"},{"key":"3287_CR46","doi-asserted-by":"crossref","first-page":"29913","DOI":"10.34172\/bi.2023.29913","volume":"14","author":"SJ Zaer","year":"2023","unstructured":"Zaer SJ, Aghamaali M, Amini M, Doustvandi MA, Hosseini SS, Baradaran B, Najafi S, Esfandyari YB, Mokhtarzadeh A (2023) Cooperatively inhibition effect of miR-143-5p and miR-145-5p in tumorigenesis of glioblastoma cells through modulating AKT signaling pathway. BioImpacts 14:29913\u201329913","journal-title":"BioImpacts"},{"key":"3287_CR47","first-page":"1363","volume":"24","author":"H Zhang","year":"2010","unstructured":"Zhang H, Cai X, Wang Y, Tang H, Tong D, Ji F (2010) microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep 24:1363\u20131369","journal-title":"Oncol Rep"},{"key":"3287_CR48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/09537104.2014.928676","volume":"26","author":"J Zhang","year":"2015","unstructured":"Zhang J, Chen M, Zhang Y, Zhao L, Yan R, Dai K (2015) Carmustine induces platelet apoptosis. Platelets 26:437\u2013442","journal-title":"Platelets"},{"key":"3287_CR49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.canlet.2013.01.039","volume":"333","author":"S Zhao","year":"2013","unstructured":"Zhao S, Liu H, Liu Y, Wu J, Wang C, Hou X, Chen X, Yang G, Zhao L, Che H (2013) miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. Cancer Lett 333:253\u2013260","journal-title":"Cancer Lett"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03287-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03287-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03287-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T09:00:51Z","timestamp":1738400451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03287-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3287"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03287-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"19 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}